Autonomic modification of intestinal smooth muscle contractility

Area of Science:

• Gastrointestinal Physiology
• Pharmacology
• Autonomic Nervous System Function

Background:

• Intestinal smooth muscle possesses intrinsic pacemaker cells responsible for spontaneous rhythmic contractions.
• The autonomic nervous system modulates, rather than initiates, intestinal motility.
• Understanding these mechanisms is crucial for managing gastrointestinal disorders.

Purpose of the Study:

• To provide students with a practical demonstration of spontaneous intestinal smooth muscle activity.
• To illustrate the modulatory effects of parasympathetic and sympathetic nervous system agents on intestinal contractions.
• To explore concepts of receptor pharmacology and drug antagonism in the context of gastrointestinal function.

Main Methods:

• Utilizing an isolated rabbit small intestine preparation in an organ bath.
• Measuring intestinal smooth muscle tension using a pressure transducer and data-acquisition software.
• Applying acetylcholine (ACh) and epinephrine to observe their effects on muscle tone and activity.
• Investigating the effects of atropine as a competitive antagonist and potassium ions on smooth muscle.

Main Results:

• Acetylcholine (ACh) increased intestinal smooth muscle tone in a dose-dependent manner, allowing for EC50 calculation.
• Epinephrine demonstrated inhibitory effects, mimicking sympathetic nerve activation.
• Atropine competitively inhibited the response to ACh.
• Potassium ions induced a depolarizing effect on the smooth muscle.

Conclusions:

• Spontaneous intestinal motility is a fundamental property of smooth muscle, influenced by autonomic neurotransmitters.
• Pharmacological agents can effectively modulate intestinal contractions, providing therapeutic targets for gastrointestinal conditions.
• This practical enhances understanding of autonomic control of the gut and principles of drug-receptor interactions.